The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation - EP3024461

The patent EP3024461 was granted to Euro Celtique on May 13, 2020. The application was originally filed on Jul 23, 2014 under application number EP14741915A. The patent is currently recorded with a legal status of "Revoked".

EP3024461

EURO CELTIQUE
Application Number
EP14741915A
Filing Date
Jul 23, 2014
Status
Revoked
Oct 29, 2021
Publication Date
May 13, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DEVELCO PHARMA SCHWEIZMay 14, 2020TER MEER STEINMEISTER & PARTNERADMISSIBLE
HEXAL PHARMAMay 14, 2020TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2011142939
INTERNATIONAL-SEARCH-REPORTUS4769372
INTERNATIONAL-SEARCH-REPORTWO2012089738

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents